Long-Term Survival of McKee-Farrar Total Hip Prostheses

Brown, Stephen R.; Davies, W. A.; DeHeer, David H.; Swanson, Alfred B.

doi:10.1097/00003086-200209000-00013

Cited by 99 publications

(48 citation statements)

References 28 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…20-year probability of implant survivorship of 84% and a 28-year implant survivorship of 74% was reported in a study of 129 patients who had McKee-Farrar hip replacement (Brown et al 2002). Another study reported a 20-year implant survivorship of 77% in 107 McKee-Farrar arthroplasties, as compared to a 20-year survivorship of 73% for Charnley low-friction arthroplasty for a similar population (Jacobsson et al 1996).…”

Section: Discussionmentioning

confidence: 93%

Uncemented metal-on-metal acetabular component

et al. 2007

View full text Add to dashboard Cite

Background Aseptic loosening is the major cause of implant failure. In cemented hip arthroplasty, failure of the acetabular side is mainly due to lysis caused by wear particles. By using an implant with low wear characteristics and by enhancing acetabular fixation using an uncemented implant, we aimed to reduce acetabular lysis and thereby loosening.Patients and methods This was a retrospective cohort study of 119 hips (101 patients) that had the Uncemented Fitmore cup (Sulzer Orthopedics). In 66 patients, the femoral component was CF-30 (Sulzer) used with cement. In the remaining 35 patients, thrust plate prosthesis (TPP) (Sulzer) was used. Of the 101 patients, 94 (112 hips) were available for study. Mean follow-up of the 94 patients was 7 (5-13) years.Results The mean preoperative Harris hip score was 38 and the mean postoperative Harris hip score was 89 at the last follow-up. Taking aseptic loosening as the endpoint, the survival rate of the Fitmore cup was 100% at 11 years.Interpretation The uncemented Fitmore acetabular cup with second generation metal-on-metal articulation showed good results with regard to aseptic loosening in the medium term.

show abstract

Section: Discussionmentioning

confidence: 93%

Uncemented metal-on-metal acetabular component

et al. 2007

View full text Add to dashboard Cite

show abstract

“…Outcomes from these surgeries are often determined through the use of patient reported, validated outcome tools [1][2][3] . Currently, total joint arthroplasty (TJA) has revolutionized the care of patients with end-stage arthritis of the hip and knee joint, by providing excellent long term results exceeding 20 years after surgery [4][5][6] . With future projections of close to 3.48 million TKAs and 572000 THAs occurring in the United States alone in the next 15 years, there is an increased importance on learning all criteria that make total joint replacement successful [7] .…”

Section: Introductionmentioning

confidence: 99%

How are those “lost to follow-up” patients really doing? A compliance comparison in arthroplasty patients

Choi¹,

Geller²,

Patrick³

et al. 2015

WJO

View full text Add to dashboard Cite

AIM:To determine whether there is a functional difference between patients who actively follow-up in the office (OFU) and those who are non-compliant with office follow-up visits (NFU). METHODS:We reviewed a consecutive group of 588 patients, who had undergone total joint arthroplasty (TJA), for compliance and functional outcomes at one to two years post-operatively. All patients were given verbal instructions by the primary surgeon to return at one year for routine follow-up visits. Patients that were compliant with the instructions at one year were placed in the OFU cohort, while those who were non-compliant were placed in the NFU cohort. Survey mailings and telephone interviews were utilized to obtain complete follow-up for the cohort. A χ 2 test and an unpaired t test were used for comparison of baseline characteristics. Analysis of covariance was used to compare the mean clinical outcomes after controlling for confounding variables. RESULTS:Complete follow-up data was collected on 554 of the 588 total patients (93%), with 75.5% of patients assigned to the OFU cohort and 24.5% assigned to the NFU cohort. We found significant differences between the cohorts with the OFU group having a higher mean age (P = 0.026) and a greater proportion of females (P = 0.041). No significant differences were found in either the SF12 or WOMAC scores at baseline or at 12 mo postoperative. CONCLUSION:Patients who are compliant to routine follow-up visits at one to two years post-operation do not experience better patient reported outcomes than those that are non-compliant. Additionally, after TJA, older women are more likely to be compliant in following surgeon instructions with regard to follow-up office care. Prospective Studyare non-compliant with the surgeon requested followup protocol. This study aims to determine if there is a functional difference between patients who actively follow-up in office and those who are non-compliant with the visit protocol. Based on our results, patient compliance to routine follow-up visits at 12-24 mo post-operation does not lead to better patient-reported functional outcomes than those who are non-compliant. Additionally, older women are more likely to be compliant in adhering to surgeon post-operative followup instructions.

show abstract

“…PI developed in 12 (3.63%) and 8 (2.95%) patients after KJ and HJ ER, respectively. Early, delayed, and late PI was seen in 11,6, and 3 patients, respectively. Eleven patients with early PI underwent joint revision/debridement with preservation of an endoprosthesis and replacement of HJ endoprosthetic inserts and heads.…”

mentioning

confidence: 92%

“…К особенностям, кото-рые также следует учитывать при планировании ЭП у стра-дающих ревматическими заболеваниями (РЗ), следует от-нести: молодой возраст пациентов, выраженный в той или иной степени остеопороз, возможность медленного зажи-вления послеоперационной раны, низкую сопротивляе-мость организма к инфекциям, анемию, обусловленную хроническим течением заболевания, сниженную физиче-скую активность, тяжесть функциональных нарушений, длительную терапию нестероидными противовоспали-тельными препаратами (НПВП), глюкокортикоидами (ГК), БПВП и генно-инженерными биологическими пре-паратами (ГИБП) [5,6].…”

unclassified